Otsuka Holdings Co., Ltd. (TYO:4578)

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Mar 31, 2014	Mar 31, 2013
Japan Revenue	718.10B	699.70B
Japan Revenue Growth	2.63%	4.29%
North America Revenue	1.17T	1.10T
North America Revenue Growth	6.74%	25.38%
Europe Revenue	284.90B	242.90B
Europe Revenue Growth	17.29%	11.06%
Others Revenue	297.00B	292.20B
Others Revenue Growth	1.64%	14.27%
Overseas Revenue	1.75T	1.63T
Overseas Revenue Growth	7.40%	20.96%

Revenue

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Mar 31, 2014	Mar 31, 2013
Pharmaceuticals Revenue	1.74T	1.63T
Pharmaceuticals Revenue Growth	7.07%	17.10%
Nutraceuticals Revenue	577.62B	557.01B
Nutraceuticals Revenue Growth	3.70%	15.25%
Consumer Products Revenue	34.61B	33.75B
Consumer Products Revenue Growth	2.54%	-8.94%
Other Segment Revenue	112.43B	110.07B
Other Segment Revenue Growth	2.14%	2.85%

Adjusted EBIT

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Mar 31, 2014	Mar 31, 2013
Pharmaceuticals Business Profit	402.02B	390.61B
Pharmaceuticals Business Profit Growth	2.92%	38.47%
Nutraceuticals Business Profit	68.91B	64.15B
Nutraceuticals Business Profit Growth	7.42%	6.09%
Consumer Products Business Profit	25.17B	23.66B
Consumer Products Business Profit Growth	6.38%	30.72%
Other Segment Business Profit	7.47B	6.95B
Other Segment Business Profit Growth	7.44%	121.83%
Eliminations from Business Profit	-57.43B	-54.91B

EBIT

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2014	FY 2013
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Mar 31, 2014	Mar 31, 2013
Pharmaceuticals Segment Profit	445.30B	285.11B
Pharmaceuticals Segment Profit Growth	56.19%	98.47%
Nutraceuticals Segment Profit	57.72B	59.78B
Nutraceuticals Segment Profit Growth	-3.44%	74.56%
Consumer Products Segment Profit	25.15B	23.00B
Consumer Products Segment Profit Growth	9.36%	89.50%
Other Segment Profit	7.98B	7.53B
Other Segment Profit Growth	6.10%	2606.84%
Eliminations from Segment Profit	-56.78B	-51.85B

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 4, 2026

Data Sources Report a data error